Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

0.34p
   
  • Change Today:
      0.020p
  • 52 Week High: 0.39
  • 52 Week Low: 0.12
  • Currency: UK Pounds
  • Shares Issued: 6,783m
  • Volume: 30,223,132
  • Market Cap: £23.06m

Latest ShareCast News

Graft Polymer to buy Awakn in £4.98m deal

By Michele Maatouk

Date: Monday 16 Dec 2024

(Sharecast News) - Biotech firm Graft Polymer said on Monday that it has agreed to buy Awakn Life Sciences Corp, a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, for £4.98m.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.34p
Change Today 0.020p
% Change 6.25 %
52 Week High 0.39
52 Week Low 0.12
Volume 30,223,132
Shares Issued 6,783m
Market Cap £23.06m

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average
2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average
Price Trend
35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average
40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
17:08 1,000,000 @ 0.34p
16:38 1,000,000 @ 0.34p
16:22 362,951 @ 0.33p
15:51 71,472 @ 0.34p
15:28 6,549 @ 0.34p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell
Finance Director Ryan Neats

Top of Page